Insider · CIK 0001820278

Torres Denice

Reports to the SEC for 7 companies · HAMPTON, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001820278

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-25	CLDXCelldex Therapeutics, Inc. · Non-Qualified Stock Option (right to buy)A Award	Director	AAward	+26K sh	—	—	26,000
2026-05-28	GKOSGLAUKOS CorpA Award	Director	AAward	+1,878 sh	—	—	24,212
2026-05-28	GKOSGLAUKOS Corp · Stock Option (Right to Buy)A Award	Director	AAward	+2,987 sh	—	—	2,987
2026-05-28	GKOSGLAUKOS Corp · Stock Option (Right to Buy)A Award	Director	AAward	+2,987 sh	—	—	2,987
2026-05-04	SPTXSeaport Therapeutics, Inc.C Conversion	Director	CConversion	+13.4K sh	—	—	13,406
2026-05-04	SPTXSeaport Therapeutics, Inc. · Series B Preferred StockC Conversion	Director	CConversion	−42.1K sh	—	—	0
2026-04-30	SPTXSeaport Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+12.3K sh	—	—	12,258
2026-01-02	GKOSGLAUKOS CorpA Award	Director	AAward	+623 sh	—	—	22,334
2025-06-05	CLDXCelldex Therapeutics, Inc. · Non-Qualified Stock Option (right to buy)A Award	Director	AAward	+33K sh	—	—	33,000
2025-05-29	GKOSGLAUKOS CorpA Award	Director	AAward	+2,108 sh	—	—	21,711
2025-05-29	GKOSGLAUKOS Corp · Stock Option (Right to Buy)A Award	Director	AAward	+3,149 sh	—	—	3,149
2025-05-13	2seventy bio, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−12.1K sh	—	—	19,510
2025-05-13	2seventy bio, Inc.U Disposition from Tender	Director	UDisposition from Tender	−19.5K sh	—	—	0
2025-05-13	2seventy bio, Inc.Stock Options (Right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−24.1K sh	—	—	0
2025-01-02	GKOSGLAUKOS CorpA Award	Director	AAward	+461 sh	—	—	19,603
2024-06-10	2seventy bio, Inc.A Award	Director	AAward	+12.1K sh	—	—	31,560
2024-06-10	2seventy bio, Inc.Stock Options (Right to buy)A Award	Director	AAward	+24.1K sh	—	—	24,100
2024-05-30	GKOSGLAUKOS CorpA Award	Director	AAward	+1,716 sh	—	—	19,142
2024-05-30	GKOSGLAUKOS Corp · Stock Option (Right to Buy)A Award	Director	AAward	+1,246 sh	—	—	1,246
2024-03-18	Karuna Therapeutics, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−990 sh	$330.00	−$327K	0
2024-03-18	Karuna Therapeutics, Inc.Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−25K sh	$225.74	−$5.64M	0
2024-03-18	Karuna Therapeutics, Inc.Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−8,500 sh	$201.99	−$1.72M	0
2024-03-18	Karuna Therapeutics, Inc.Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−5,000 sh	$227.04	−$1.14M	0
2024-03-18	Karuna Therapeutics, Inc.Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−1,904 sh	$92.30	−$176K	0
2024-01-02	GKOSGLAUKOS CorpA Award	Director	AAward	+895 sh	—	—	17,426
2023-06-20	Karuna Therapeutics, Inc.A Award	Director	AAward	+990 sh	—	—	990
2023-06-20	Karuna Therapeutics, Inc.Option (right to buy)A Award	Director	AAward	+1,904 sh	—	—	1,904
2023-06-13	2seventy bio, Inc.A Award	Director	AAward	+8,400 sh	—	—	19,510
2023-06-13	2seventy bio, Inc.Stock Option (right to buy)A Award	Director	AAward	+16.9K sh	—	—	16,900
2023-06-01	GKOSGLAUKOS CorpA Award	Director	AAward	+3,230 sh	—	—	16,531
2023-01-03	GKOSGLAUKOS CorpA Award	Director	AAward	+1,572 sh	—	—	13,301
2022-06-15	Karuna Therapeutics, Inc.Option (right to buy)A Award	Director	AAward	+5,000 sh	—	—	5,000
2022-06-08	2seventy bio, Inc.A Award	Director	AAward	+8,200 sh	—	—	11,110
2022-06-08	2seventy bio, Inc.Stock Option (right to buy)A Award	Director	AAward	+16.9K sh	—	—	16,900
2022-06-08	Surface Oncology, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+24K sh	—	—	24,000
2022-06-02	GKOSGLAUKOS CorpA Award	Director	AAward	+4,364 sh	—	—	11,729
2022-01-03	GKOSGLAUKOS CorpA Award	Director	AAward	+1,455 sh	—	—	7,365
2022-01-03	Surface Oncology, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+12K sh	—	—	12,000
2021-11-11	2seventy bio, Inc.A Award	Director	AAward	+492 sh	—	—	492
2021-11-11	2seventy bio, Inc.A Award	Director	AAward	+2,002 sh	—	—	2,910
2021-11-11	2seventy bio, Inc.Stock Option (right to buy)A Award	Director	AAward	+1,476 sh	—	—	1,476
2021-11-11	2seventy bio, Inc.Stock Option (right to buy)A Award	Director	AAward	+3,219 sh	—	—	3,219
2021-11-11	bluebird bio, Inc.J Other	Director	JOther	+1,476 sh	—	—	2,726
2021-11-11	bluebird bio, Inc.J Other	Director	JOther	0 sh	—	—	2,726
2021-11-11	bluebird bio, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−4,500 sh	—	—	4,430
2021-11-11	bluebird bio, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−5,000 sh	—	—	0
2021-08-02	Surface Oncology, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+36K sh	—	—	36,000
2021-06-16	Karuna Therapeutics, Inc.Option (right to buy)A Award	Director	AAward	+8,500 sh	—	—	8,500
2021-06-15	bluebird bio, Inc.A Award	Director	AAward	+3,109 sh	—	—	5,859
2021-06-15	bluebird bio, Inc.Stock Option (right to buy)A Award	Director	AAward	+5,000 sh	—	—	5,000

Recent filings

Accepted (ET)
Jun 294
Torres Denice0001820278-26-000008
SEC(opens sec.gov)
Jun 234/A
Torres Denice0001820278-26-000006
SEC(opens sec.gov)
Jun 14
Torres Denice0001820278-26-000004
SEC(opens sec.gov)
May 44
Torres Denice0001193125-26-204468
SEC(opens sec.gov)
Jan 74
Torres Denice0001820278-26-000002
SEC(opens sec.gov)
Jun 94
Torres Denice0001415889-25-016226
SEC(opens sec.gov)
Jun 24
Torres Denice0001415889-25-015167
SEC(opens sec.gov)
May 154
Torres Denice0001562180-25-003880
SEC(opens sec.gov)
Jun 124
Torres Denice0001562180-24-005006
SEC(opens sec.gov)
Jun 34
Torres Denice0001415889-24-015240
SEC(opens sec.gov)
Mar 184
Torres Denice0001140361-24-013934
SEC(opens sec.gov)

Companies

Address

C/O CELLDEX THERAPEUTICS, INC. 53 FRONTAGE ROAD, SUITE 220

HAMPTON, NJ, 08827